PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Overview Fund Activity
Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

66 hedge funds and large institutions have $178M invested in Poseida Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
+1
Holders Change %
+1.54%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
18
Reduced
16
Closed
17
Calls
$24K
Puts
$13K
Net Calls
+$11K
Net Calls Change
-$621K

Top Buyers

1
N
1
Natixis
France
$11.6M
2
SCM
2
Silverarc Capital Management
Massachusetts
$1.6M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$3.34M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$663K
5
GCP
5
GSA Capital Partners
United Kingdom
$577K

Top Sellers

1
PA
1
Perceptive Advisors
New York
$0
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$0
3
JGC
3
J. Goldman & Co
New York
$0
4
SSA
4
Schonfeld Strategic Advisors
New York
$0
5
MA
5
MCF Advisors
Kentucky
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Invesco
76
Invesco
Georgia
– -$85K -11,629 Closed
PCM
77
Penserra Capital Management
California
– -$10K -1,425 Closed
Nisa Investment Advisors
78
Nisa Investment Advisors
Missouri
– -$4 -600 Closed
Simplex Trading
79
Simplex Trading
Illinois
– -$1K -181 Closed
AF
80
Allworth Financial
California
– -$1K -100 Closed
S
81
SignatureFD
Georgia
– -$1K -98 Closed
1 2 3
4